ETP Nanomedicine forum to take place in Italy on 14 and 15 October 2010

The 5th General Assembly & Annual Forum of the European Technology Platform on Nanomedicine will take place at Centro Congressi Fondazione Cariplo in Milan, Italy on 14 and 15 October 2010.

This event is dedicated to the members of ETP Nanomedicine and to the European Nanomedicine Community at large.

"Nanomedicine is experiencing substantial and continued interest from the research community as well as from the industrial and societal side. The event will provide an excellent opportunity to exchange current ideas, trends and possibilities with the European key members", says Bertrand Loubaton, Director at GE Healthcare and chairman of the Technology Platform.

This year the ETP will essentially focus on discussing strategic opportunities for the Nanomedicine stakeholders coming from industry, academia, clinics and the public sector. The European Commission (DG RTD) will also be present to discuss the development of the European Nanomedicine policy. Furthermore, a key target of this forum will be to raise awareness for translational research, clinical needs and necessary conditions to make Nanomedicine happen in Europe. In particular, this year's event will focus on the identification of industrial opportunities and needs, on the strategies for adapting regulations, funding schemes and infrastructures, on clinical challenges and on translational strategies of Nanomedicine.

For the first time an "Open Presentations Session" will be offered to the participants to present their latest project designs or technology offers.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Squid-inspired technology could replace needles for medications and vaccines